Clinical Trials List
2026-03-20 - 2028-01-27
Phase I
Not yet recruiting4
ICD-10C33
Malignant neoplasm of trachea
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.0
Malignant neoplasm of trachea
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Mei-Chuan Chen Division of Thoracic Medicine
- 高冠鈞 Division of Thoracic Medicine
- Shang-Fu Hsu Division of Thoracic Medicine
- Kai-Ling Lee Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Chi-Lu Chiang Division of Thoracic Medicine
- 廖映庭 Division of Thoracic Medicine
- 趙恒勝 Division of Thoracic Medicine
- 蕭慈慧 Division of Thoracic Medicine
- Chia-I Shen Division of Thoracic Medicine
- Hsu-ching Huang Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Chih-Hung Chen Division of Hematology & Oncology
- 枋岳甫 Division of Hematology & Oncology
- Shih-Hong Li Division of Hematology & Oncology
- 吳振德 Division of Hematology & Oncology
- 柯皓文 Division of Hematology & Oncology
- 邱立忠 Division of Hematology & Oncology
- Jia-Shiuan Ju Division of Hematology & Oncology
- Chih-Liang Wang Division of Hematology & Oncology
- Chih-Hsi Kuo Division of Hematology & Oncology
- 黃振洋 Division of Hematology & Oncology
- Cheng-Ta Yang Division of Hematology & Oncology
- 林定佑 Division of Hematology & Oncology
- 吳教恩 Division of Hematology & Oncology
- 張美元 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 陳昭勳 Division of Hematology & Oncology
- 蕭聖諺 Division of Hematology & Oncology
- 曹朝榮 Division of Hematology & Oncology
- 林正耀 Division of Hematology & Oncology
- 陳冠宇 Division of Hematology & Oncology
- Shang-Wen Chen Division of Hematology & Oncology
- 高婉真 Division of Hematology & Oncology
- 黃文聰 Division of Hematology & Oncology
- 陳彥勳 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
11 participants
-
Global
40 participants